Market Cap: $21.82M
LI
Lantern Pharma Inc.
LTRN
NASDAQ (NASDAQ Capital Market)USD
Market Cap: $21.82M
Filed a patent for "treating liver cancers with acylfulvenes" on Wed, August 23, 2023
New US PatentFiled a patent for "treating cancers with combinations of anti-cd20 antibody and acylfulvenes" on Tue, May 30, 2023
New US PatentFiled a patent for "detachable skateboard assembly" on Thu, November 23, 2023
New US PatentFiled a patent for "cancer drug sensitivity determining markers" on Thu, September 28, 2023
New US PatentFiled a patent for "method for treating blood cancers" on Thu, March 14, 2024
New US Patent